European Union - English - EMA (European Medicines Agency)

bayer ag - riociguat - hypertension, pulmonary - antihypertensives for pulmonary arterial hypertension - chronic thromboembolic pulmonary hypertension (cteph) adempas is indicated for the treatment of adult patients with who functional class (fc) ii to iii withinoperable cteph,persistent or recurrent cteph after surgical treatment,to improve exercise capacity. pulmonary arterial hypertension (pah) adempas, as monotherapy or in combination with endothelin receptor antagonists, is indicated for the treatment of adult patients with pulmonary arterial hypertension (pah) with who functional class (fc) ii to iii to improve exercise capacity. efficacy has been shown in a pah population including aetiologies of idiopathic or heritable pah or pah associated with connective tissue disease.

Ireland - English - HPRA (Health Products Regulatory Authority)

rowex ltd - acetylsalicylic acid - gastro-resistant tablet - 75 milligram(s) - platelet aggregation inhibitors excl. heparin; acetylsalicylic acid - antithrombotic agents: platelet aggregation inhibitors excl. heparin - it is used for: secondary prevention of myocardial infarction, prevention of cardiovascular morbidity in patients suffering from stable angina pectoris, history of unstable angina pectoris, except during the acute phase, prevention of graft occlusion after coronary artery bypass grafting (cabg), coronary angioplasty, except during the acute phase, secondary prevention of transient ischaemic attacks (tia) and ischaemic cerebrovascular accidents (cva), provided intracerebral haemorrhages have been ruled out.

Ireland - English - HPRA (Health Products Regulatory Authority)

krka, d.d., novo mesto - acetylsalicylic acid - gastro-resistant tablet - 75 milligram(s) - platelet aggregation inhibitors excl. heparin; acetylsalicylic acid

United States - English - NLM (National Library of Medicine)

4medical group llc - aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e) -